Time to reduce implementation gaps of lipid-lowering therapy

10' education - Nov. 6, 2020 - Prof Kausik Ray, MD - London, UK - Online CME

Video navigation menu

ESC/EAS risk-based LDL-c goals 00:56
The basis of the lower LDL-c recommendation for clinical practice 01:58
Use of lipid-lowering treatments and their impact on health and disease outcomes 02:32
Implementation gaps and how combination therapy can overcome this 04:04
Summary 08:58

Educational information

This presentation by Prof. Kausik Ray, MD was part of the EBAC-accredited symposium "PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities" held during the virtual ESC Congress 2020.

Faculty

Prof. Kausik Ray, MD, is a cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Sanofi and Amgen

Online-CME

This is available as accredited online CME on coursepath for members. Click the button below to enroll:

Enroll

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.